INHALATION CHARACTERISTICS WITH SPIROMAX® AND TURBUHALER® DRY POWDER INHALERS (DPI) IN HEALTHY ADULTS AND PATIENTS WITH ASTHMA OR CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD): BEFORE AND AFTER ENHANCED TRAINING

被引：2

作者：

Chrystyn, H. ^{[1
]}

Azouz, W. ^{[1
]}

Chetcuti, P. ^{[2
]}

Hosker, H. ^{[3
]}

Saralaya, D. ^{[4
]}

机构：

[1] Univ Huddersfield, Huddersfield HD1 3DH, W Yorkshire, England

[2] Leeds Gen Infirm, Leeds, W Yorkshire, England

[3] Airedale Dist Gen Hosp, Bradford, W Yorkshire, England

[4] Bradford Royal Infirm, Bradford BD9 6RJ, W Yorkshire, England

来源：

THORAX | 2013年 / 68卷

关键词：

D O I：

10.1136/thoraxjnl-2013-204457.378

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

引用

页码：A178 / A179

页数：2

共 50 条

[41] Ciprofloxacin Dry Powder for Inhalation in Patients with Non-Cystic Fibrosis Bronchiectasis or Chronic Obstructive Pulmonary Disease, and in Healthy Volunteers (vol 30, pg 53, 2017)
Stass, Heino
JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY, 2017, 30 (06) : 451 - 451
[42] The economic impact of educational training assessed by the Handling Questionnaire with three inhalation devices in asthma and Chronic Obstructive Pulmonary Disease patients
Dal Negro, Roberto W.
Povero, Massimiliano
CLINICOECONOMICS AND OUTCOMES RESEARCH, 2016, 8 : 171 - 176
[43] Safety, Tolerability And Pharmacokinetics Of Ciprofloxacin Dry Powder For Inhalation In Patients With Mild To Moderate Chronic Obstructive Pulmonary Disease: A Randomized Controlled Trial
Stass, H.
Nagelschmitz, J.
Weimann, B.
Timmer, W.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
[44] PREFERENCES FOR DRY POWDER INHALER ATTRIBUTES AMONG PATIENTS WITH ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE FROM FIVE EUROPEAN COUNTRIES
Hawken, N. A.
Amri, I
Neine, Elmoctar M.
Aballea, S.
Torvinen, S.
Plich, A.
VALUE IN HEALTH, 2015, 18 (07) : A364 - A364
[45] Real-life budesonide and formoterol dose emission from the medium and high strength fixed dosed combinations in a Spiromax® dry powder inhaler using inhalation profiles from patients with chronic obstructive pulmonary disease
Bagherisadeghi, Golshan
Chrystyn, Henry
Abadelah, Mohamad
Larhrib, El Hassane
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2019, 139
[46] Assessment of respiratory muscle functions before and after exercise training in stable chronic obstructive pulmonary disease patients
Eshmawey, Heba A.
Hassan, Maged
EGYPTIAN JOURNAL OF CHEST DISEASES AND TUBERCULOSIS, 2020, 69 (01): : 56 - 63
[47] Real-world experience with a new dry powder inhaler for asthma/chronic obstructive pulmonary disease (COPD): patient satisfaction, preference and ease of use
Gillissen, A.
Schneidereit, R.
Gessner, C.
Herth, F. J.
Kanniess, F.
Kardos, P.
Lommatzsch, M.
Windisch, W.
ALLERGY, 2016, 71 : 258 - 258
[48] IDENTIFICATION OF DRY POWDER INHALER ATTRIBUTES, AND THEIR RELATIVE IMPORTANCE TO ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE PATIENTS, TO INFORM A DISCRETE CHOICE EXPERIMENT
Hawken, N. A.
Aballea, A. S.
Torvinen, S.
Plich, A.
VALUE IN HEALTH, 2014, 17 (07) : A600 - A600
[49] Differences in Healthcare Resource Use and Costs Between Post-Discharge Chronic Obstructive Pulmonary Disease Patients Treated with Dry-Powder Inhalers and Pressurized Metered-Dose Inhalers
Wittbrodt, E. T.
Millette, L.
Ferguson, G. T.
Evans, K.
Bonafede, M.
Tkacz, J.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
[50] Use of Health Care Services in Patients with Chronic Obstructive Pulmonary Disease (COPD) Using Budesonide/Formoterol Via Dry Powder Inhaler (BUD/FM DPI) Versus Fluticasone Propionate/Salmeterol (FP/SM).
Blais, L.
Forget, A.
Ramachandran, S.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179

← 1 2 3 4 5 →